Robert C. Baxter

28.1k citations

397 papers · 22.9k indexed · 5 hit papers · h-index 78

Endocrinology, Diabetes and Metabolism top 0.01%
- Growth Hormone and Insulin-like Growth Factors 286
- Pituitary Gland Disorders and Treatments 17
Cancer Research top 0.1%
- Cancer, Hypoxia, and Metabolism 84
Molecular Biology top 0.2%
- Metabolism, Diabetes, and Cancer 120
Cardiology and Cardiovascular Medicine top 0.5%
- Lipid metabolism and disorders 44
Genetics top 0.2%
Surgery
- Pancreatic function and diabetes 33
Clinical Biochemistry
- Metabolism and Genetic Disorders 19
Physiology
- Diet and metabolism studies 17

Co-authors: Janet L. Martin Sue M. Firth Carolyn D. Scott John R. Turtle Moira Lewitt Alison J. Butt Lynette J. Schedlich Stephen M. Twigg
Cited by: Endocrinology, Diabetes and Metabolism Cancer Research Molecular Biology
Journals: Endocrinology (61 papers)The Journal of Clinical Endocrinology & Metabolism (56 papers)Journal of Biological Chemistry (26 papers)
Partner nations: Australia United States United Kingdom

In The Last Decade

Robert C. Baxter

391 papers receiving 22.3k citations

Hit Papers

5 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2014 Nature reviews. Cancer
2002 Endocrine Reviews
1989 PubMed
1988 Biochemical and Biophysical Research Communications
1986 Journal of Clinical Investigation

Peers

Countries citing papers authored by Robert C. Baxter

Since Specialization

Citations

This map shows the geographic impact of Robert C. Baxter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Baxter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Baxter more than expected).

Fields of papers citing papers by Robert C. Baxter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert C. Baxter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Baxter. The network helps show where Robert C. Baxter may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Robert C. Baxter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert C. Baxter Line = papers co-authored together Robert C. Baxter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Limitations of galactose therapy in phosphoglucomutase 1 deficiency Molecular Genetics and Metabolism Reports ·Yingshi Huang,Julien H. Park,Jianlong Xu,Hebatallah Shoukry,Marianne Grüneberg,Stephan Rust,Janine Reunert,Lubna S. O.Mohamed,Volker Debus,Eric Schulze‐Bahr,Robert C. Baxter,Yoshinao Wada,Christian Thiel,Emile Van Schaftingen,Ralph Fingerhut,Thorsten Marquardt	2017	27
2	Cotargeting of Epidermal Growth Factor Receptor and PI3K Overcomes PI3K–Akt Oncogenic Dependence in Pancreatic Ductal Adenocarcinoma Clinical Cancer Research ·Matthew H. Wong,Aiqun Xue,Sohel M. Julovi,Nick Pavlakis,Jaswinder S. Samra,Thomas J. Hugh,Anthony J. Gill,A. D'Amore,Robert C. Baxter,Ross C. Smith	2014	33
3	CCN2 requires TGF-β signalling to regulate CCAAT/enhancer binding proteins and inhibit fat cell differentiation Journal of Cell Communication and Signaling ·William Wei Song,Susan V. McLennan,Charmaine S. Tam,Paul F. Williams,Robert C. Baxter,Stephen M. Twigg	2014	10
4	Inhibition of Insulin-like Growth Factor–Binding Protein-3 Signaling through Sphingosine Kinase-1 Sensitizes Triple-Negative Breast Cancer Cells to EGF Receptor Blockade Molecular Cancer Therapeutics ·Janet L. Martin,Vladimir V. Dik,Mike Z. Lin,Carolyn D. Scott,Robert C. Baxter	2013	62
5	The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents Oncogene ·Mike Z. Lin,LI Peng-xianga,Janet L. Martin,Robert C. Baxter	2012	61
6	Profiling of Apoptotic Changes in Human Breast Cancer Cells Using SELDI-TOF Mass Spectrometry Cellular Physiology and Biochemistry ·华吴,Richard I. Christopherson,Robert C. Baxter	2007	27
7	Proteomic profiling of cholangiocarcinoma: Diagnostic potential of SELDI-TOF MS in malignant bile duct stricture Hepatology ·Christopher J. Scarlett,Hailong Xu,Sidney Artemio,Cameron Bell,Jaswinder S. Samra,Thomas J. Hugh,Robert C. Baxter,Ross C. Smith	2006	38
8	Amino- and Carboxyl-Terminal Fragments of Insulin-Like Growth Factor (IGF) Binding Protein-3 Cooperate to Bind IGFs with High Affinity and Inhibit IGF Receptor Interactions Endocrinology ·Betânia Guedes Souza e Brito,Xiuhong Wang,Robert C. Baxter,Sue M. Firth	2003	39
9	IGF-Binding Protein-3-Induced Growth Inhibition and Apoptosis Do Not Require Cell Surface Binding and Nuclear Translocation in Human Breast Cancer Cells Endocrinology ·Alison J. Butt,Martin Schwab,Sue M. Firth,Robert C. Baxter	2002	79
10	What Is the Significance of IGF-Binding Protein-3 Proteolysis in the Circulation? The Journal of Clinical Endocrinology & Metabolism ·Robert C. Baxter	2001	2
11	Mutagenesis of Basic Amino Acids in the Carboxyl-Terminal Region of Insulin-Like Growth Factor Binding Protein-5 Affects Acid-Labile Subunit Binding Endocrinology ·Sue M. Firth,David R. Clemmons,Robert C. Baxter	2001	23
12	Competitive Binding Assay for Determination of Rat Insulin-Like Growth Factor Binding Protein-3 Endocrinology ·Jan Frystyk,Robert C. Baxter	1998	7
13	Developmental Changes in Serum Levels of Free and Total Insulin-Like Growth Factor I (IGF-I), IGF-Binding Protein-1 and -3, and the Acid-Labile Subunit in Rats*This work was supported by grants from the Danish Health Research Council (Grants 9602012 and 9700592), the Aarhus University-Novo Nordisk Center for Research in Growth and Regeneration (Danish Health Research Council Grant 9600822), the Institute of Experimental Clinical Research, University of Aarhus, the Novo Foundation, the Nordic Insulin Foundation, and the National Health and Medical Research Council of Australia (to R.C.B.). Endocrinology* ·Jan Frystyk,Henning Grønbæk,Casper Skjærbæk,Allan Flyvbjerg,Hans Ørskov,Robert C. Baxter	1998	39
14	Characterization of Truncated Insulin-Like Growth Factor-Binding Protein-2 in Human Milk* Endocrinology ·Pin Ho,Robert C. Baxter	1997	52
15	Modulation of human IGF binding protein-3 activity by structural modification PubMed ·Robert C. Baxter,Sue M. Firth	1995	16
16	Radioimmunoassay for Insulin-Like Growth Factor (IGF). II: Interference by Pure IGF-Binding Proteins Journal of Immunoassay ·Robert C. Baxter	1990	12
17	Production of insulin-like growth factor-II by human fetal pancreas in culture Journal of Endocrinology ·Janet M. Bryson,Bernard E. Tuch,Robert C. Baxter	1989	25
18	Immunofluorescent localization of type II insulin-like growth factor receptor in rat liver and hepatoma cells Journal of Endocrinology ·Mariana A. Hartshorn,Carolyn D. Scott,Robert C. Baxter	1989	30
19	The Insulin-Like Growth Factor-II (IGF II) Receptor from Rat Brain Is of Lower Apparent Molecular Weight than the IGF II Receptor from Rat Liver* Endocrinology ·A. McElduff,Philip Poronnik,Robert C. Baxter	1987	14
20	Interactions of Oxygen at High Pressure and Radiation in Drosophila The Journal of General Physiology ·Du Shi,Robert C. Baxter,Wallace O. Fenn	1966	6

About Robert C. Baxter

Robert C. Baxter is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Clinical Biochemistry, having authored 397 papers that have together received 22.9k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (286 papers), Metabolism, Diabetes, and Cancer (120 papers), Cancer, Hypoxia, and Metabolism (84 papers), Lipid metabolism and disorders (44 papers), Pancreatic function and diabetes (33 papers), Metabolism and Genetic Disorders (19 papers), Diet and metabolism studies (17 papers) and Pituitary Gland Disorders and Treatments (17 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (16.0k citations), Cancer Research (4.4k citations) and Molecular Biology (10.4k citations). Robert C. Baxter has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Janet L. Martin, Sue M. Firth, Carolyn D. Scott, John R. Turtle, Moira Lewitt, Alison J. Butt, Lynette J. Schedlich, Stephen M. Twigg, Patric J. D. Delhanty and Pin Ho. Their work appears in journals such as Endocrinology, The Journal of Clinical Endocrinology & Metabolism, Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Journal of Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact